CD1-MR1 2017* MAIT cells and other innate-like lymphocytes in blood and synovial fluid of rheumatoid arthritis and related autoimmune arthritis (#75)
1:15 PM
The relationship between IL-7Rα polymorphisms and MAIT cell dysfunction in treated HIV-1 infection (#77)
1:15 PM
Characterization of MR-1 tetramer-positive cells in a cynomolgus macaque model of M. tuberculosis/SIV coinfection (#79)
1:15 PM
MAIT cells protect against fatal pulmonary infection by Legionella species via IFNg and can be augmented by synthetic ligands. (#81)
1:15 PM
MAIT cells’ in vivo activation requirements (#83)
1:15 PM
Anti-HIV-1 effector potential of mucosal-associated invariant T (MAIT) cells (#85)
1:15 PM
The TCR Trap: detecting the number and structure of lipids in CD1-TCR complexes (#87)
1:15 PM
Sugar mimetics in α-galactosylceramide analogues: Potent immunostimulating agents via iNKT activation (#89)
1:15 PM
A Jurkat based NFκB-eGFP iNKT reporter cell line to evaluate the interaction of food-derived lipids with iNKT cell receptors (#91)
1:15 PM
The ceramide structure of sulfatide-analogues influences the functional activity of type II NKT cells (#93)
1:15 PM
CD1b tetramers identify T cells that recognize natural and synthetic diacylated sulfoglycolipids from Mycobacterium tuberculosis (#95)
1:15 PM
A multi-tetramer flow cytometry panel for studying the phenotypes of human donor-unrestricted T cells in clinical studies (#97)
1:15 PM
Recognition of a microbial glycolipid antigen by both Type 1 and Type 2 NKT cells (#99)
1:15 PM
Development of humanized mouse models for in vivo studies of human iNKT cells (#103)
1:15 PM
Targeting S1P to restore NKT cell responses to lymphoma (#107)
1:15 PM
A proteomics screen to identify MR1 associated proteins and implications for MR1 function (#109)
1:15 PM
A Tail of MR1 Internalization (#111)
1:15 PM
A whole genome mouse siRNA screen to identify novel genes involved in lipid antigen presentation (#113)
1:15 PM
Redistribution of functionally impaired MAIT cells to bile ducts in primary sclerosing cholangitis (#115)
1:15 PM
A phase I vaccination study with dendritic cells loaded with NY-ESO-1 and a-galactosylceramide: induction of polyfunctional T cells in high-risk melanoma patients (#117)
1:15 PM
Loss and exhaustion of MAIT cells in cholangiocarcinoma (#119)
1:15 PM
IL-21 maintains CD62L expression during NKT-cell ex vivo expansion and enhances antitumor activity of NKT cell therapy in vivo (#121)
1:15 PM
Investigating the role of human MAIT cells in breast duct carcinogenesis (#123)
1:15 PM
Activation of MAIT cells by adenovirus vectors (#125)
1:15 PM
Novel agonists to explore the function of mucosal-associated invariant T (MAIT) cells as cellular adjuvants (#127)
1:15 PM
Harnessing unconventional T cells and their targets for immunotherapy with high affinity bi-specific TCRs (#129)
1:15 PM
NKT cells control tumor associated macrophages and metastatic growth in neuroblastoma (#131)
1:15 PM
Understanding the generation of CD1c-restricted self-lipid antigen in leukemia cells (#133)
1:15 PM
NKT cells expressing a GD2-specific chimeric antigen receptor with CD28 endodomain and IL-15 undergo dramatic in vivo expansion and mediate long-term tumor control in a metastatic model of neuroblastoma (#135)
1:15 PM
Epigenetic induction of CD1d expression primes lung cancer cells for killing by invariant NKT cells (#137)
1:15 PM
Curative efficacy of intranasal HPV vaccine supplemented with aGalCer adjuvant in preclinical mouse vaginal HPV tumor model (#139)
1:15 PM
The conserved nature of CD1 and T-cell receptor interactions between humans and non-human primates (#143)
1:15 PM
IRE1alpha Regulate Cytokine mRNAs Stabilization Within Invariant NKT1 and 17 Cells (#145)
1:15 PM
Human CD8-negative MAIT cells are functionally distinct from CD8-positive MAIT cells (#147)
1:15 PM
CCR7 defines a multipotent progenitor for iNKT cells in thymus and periphery (#149)
1:15 PM
Ectopic expression of PLZF results in an RORγt positive cytotoxic T cell subset (#151)
1:15 PM
Dysfunction of mitochondrial complex III preferentially affects the development of CD1d-restricted NKT cells and Mucosal associated invariant T (MAIT) cells (#153)
1:15 PM
Differential glycosylation of the CD8a homodimer regulates binding to the non-classical MHC I, H2-Q10 (#155)
1:15 PM
Development and function of mucosal-associated invariant T cells are regulated by the micro-RNA miR-155. (#157)
1:15 PM
RIP inflammatory pathways are required to maintain iNKT cell homeostasis and enable cognate neutrophil-iNKT cell interaction (#159)
1:15 PM
Differences in the effector functions of MR1- and cytokine stimulated MAIT cells (#161)
1:15 PM
Transcriptional profiling of peripheral invariant NKT subsets (#163)
1:15 PM
Characterization of CD1a-restricted T cells using CD1a-lipid tetramers (#165)
1:15 PM
MAIT cells exacerbate the disease course of oxazolone-induced colitis. (#167)
1:15 PM
Altered cellular metabolism in Mucosal-associated invariant T cells from obese patients (#169)
1:15 PM
Impact of MAIT cells in obesity and Type 2 Diabetes (#171)
1:15 PM
Diverse Natural Killer T cells regulate inflammation, neurological injury and mortality in cardiac arrest and resuscitation. (#173)
1:15 PM
The possible role of the IL-33/iNKT cell axis during kidney ischemia-reperfusion injury (#175)
1:15 PM
Detection of polymorphisms in nonhuman primate MR-1 alleles (#177)
1:15 PM
The GM2 ganglioside inhibits iNKT cell responses in a CD1d-dependent manner (#179)
1:15 PM
Innate T cells are significantly altered in the livers of patients with alcoholic liver disease (#181)
1:15 PM
Mucosal associated invariant T (MAIT) cell dynamics during acute HIV-1 infection (#183)
1:15 PM
MAIT cells in the human oral mucosa exhibit a CD69+/CD103+ tissue resident memory phenotype and lowered cytolytic potential (#185)
1:15 PM
Gamma delta T cells producing IL-17A regulate adipose Treg homeostasis and thermogenesis (#187)
1:15 PM
Lipid antigens in bile from patients with liver diseases activate NKT cells (#189)
1:15 PM
6-FP Pretreatment Demonstrates an MR1 Recycling Pathway (#193)
1:15 PM